Tecnicas Reunidas (TRE) Q3 2026 earnings summary

Executive summary

• 9M 2026 sales were €4,794.4m and reported EBIT was €202.6m, including a €45m Middle East conflict impact; net profit was €119.3m.

• Order intake reached €7,552m and backlog a record €14,141m; 2026 sales and EBIT guidance increased to >€6.5bn and €295m.

Financial highlights

• 9M net revenues were €4,794.4m versus €4,596.4m; Q3 sales were €1,734m, up 17% QoQ.

• Reported 9M EBIT was €202.6m versus €204.5m; underlying EBIT rose 21% to €247.6m.

• EBITDA was €233.3m versus €232.0m; continuing-operations net profit rose 10% to €119.3m and profit attributable to owners rose 12% to €119.6m.

• 9M order intake was €7,552m, up 98% YoY; backlog was €14,141m versus €11,541m.

Outlook and guidance

• 2026 sales guidance rose to >€6.5bn and EBIT guidance to €295m from ~€280m, with margin guidance of ~4.5%.

• No further Middle East conflict provisions were expected beyond those recognized earlier in 2026.